160 related articles for article (PubMed ID: 9731958)
1. Pathophysiology of scleroderma: an update.
Haustein UF; Anderegg U
J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):1-8. PubMed ID: 9731958
[TBL] [Abstract][Full Text] [Related]
2. [Physiopathology of scleroderma].
Fleischmajer R; Perlish JS; Maquart FX; Kalis B
Ann Dermatol Venereol; 1993; 120(2):157-66. PubMed ID: 8363310
[TBL] [Abstract][Full Text] [Related]
3. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
[TBL] [Abstract][Full Text] [Related]
4. [Pathophysiology of fibroses. Progressive systemic scleroderma as a model disease].
Hein R; Mauch C; Braun-Falco O; Krieg T
Hautarzt; 1988 Feb; 39(2):65-71. PubMed ID: 3283077
[TBL] [Abstract][Full Text] [Related]
5. [Immunopathological disturbances in systemic sclerosis].
Gindzieńska-Sieśkiewicz E; Klimiuk PA; Kowal-Bielecka O; Sierakowski S
Pol Merkur Lekarski; 2005 Dec; 19(114):800-3. PubMed ID: 16521427
[TBL] [Abstract][Full Text] [Related]
6. [Pathogenesis of skin scleroderma--literature review].
Wojas-Pelc A; Lipko-Godlewska S
Przegl Lek; 2005; 62(5):310-3. PubMed ID: 16334538
[TBL] [Abstract][Full Text] [Related]
7. Activation of dermal connective tissue in scleroderma.
Kähäri VM
Ann Med; 1993 Dec; 25(6):511-8. PubMed ID: 8292298
[TBL] [Abstract][Full Text] [Related]
8. Immunopathogenesis of scleroderma--evolving concepts.
Sapadin AN; Esser AC; Fleischmajer R
Mt Sinai J Med; 2001; 68(4-5):233-42. PubMed ID: 11514910
[TBL] [Abstract][Full Text] [Related]
9. [Pathogenesis of systemic scleroderma: immunological aspects].
Mouthon L; García De La Peña-Lefebvre P; Chanseaud Y; Tamby MC; Boissier MC; Guillevin L
Ann Med Interne (Paris); 2002 May; 153(3):167-78. PubMed ID: 12218899
[TBL] [Abstract][Full Text] [Related]
10. [Vascular manifestations in systemic sclerosis (scleroderma)].
Cafagna D; Melon F; Balbi M; Ponte E
Minerva Med; 1998 May; 89(5):153-61. PubMed ID: 9676180
[TBL] [Abstract][Full Text] [Related]
11. Scleroderma--pathophysiology.
Yamamoto T
Eur J Dermatol; 2009; 19(1):14-24. PubMed ID: 19059831
[TBL] [Abstract][Full Text] [Related]
12. Update on pathophysiology of scleroderma with special reference to immunoinflammatory events.
Chizzolini C
Ann Med; 2007; 39(1):42-53. PubMed ID: 17364450
[TBL] [Abstract][Full Text] [Related]
13. A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease.
Ruzek MC; Jha S; Ledbetter S; Richards SM; Garman RD
Arthritis Rheum; 2004 Apr; 50(4):1319-31. PubMed ID: 15077316
[TBL] [Abstract][Full Text] [Related]
14. [Systemic sclerosis (scleroderma): etiology and pathogenesis--where are we today?].
Stoll T; Brühlmann P; Fontana A; Gmür J; Michel BA
Schweiz Med Wochenschr; 1994 Feb; 124(5):193-203. PubMed ID: 8128201
[TBL] [Abstract][Full Text] [Related]
15. Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets.
Gabrielli A; Svegliati S; Moroncini G; Luchetti M; Tonnini C; Avvedimento EV
Autoimmun Rev; 2007 Dec; 7(2):121-6. PubMed ID: 18035321
[TBL] [Abstract][Full Text] [Related]
16. Systemic sclerosis-scleroderma.
Haustein UF
Dermatol Online J; 2002 Jun; 8(1):3. PubMed ID: 12165213
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
[TBL] [Abstract][Full Text] [Related]
18. Scleroderma: from cell and molecular mechanisms to disease models.
Abraham DJ; Varga J
Trends Immunol; 2005 Nov; 26(11):587-95. PubMed ID: 16168711
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of type I collagen induced by microfibril-associated glycoprotein 2: novel mechanistic insights into the molecular basis of dermal fibrosis in scleroderma.
Lemaire R; Korn JH; Shipley JM; Lafyatis R
Arthritis Rheum; 2005 Jun; 52(6):1812-23. PubMed ID: 15934076
[TBL] [Abstract][Full Text] [Related]
20. The immunobiology of systemic sclerosis.
Gu YS; Kong J; Cheema GS; Keen CL; Wick G; Gershwin ME
Semin Arthritis Rheum; 2008 Oct; 38(2):132-60. PubMed ID: 18221988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
